Disease Control Priorities Network (DCPN), funded in 2010 by the Bill & Melinda Gates Foundation, is a multi-year project managed by University of Washington’s Department of Global Health (UW-DGH) and the Institute for Health Metrics and Evaluation (IHME). UW-DGH leads and coordinates two key components to promote and support the use of economic evaluation for priority setting at both global and national levels.
Disease Control Priorities, 3rd edition
UW-DGH coordinated and managed the production of the 3rd Edition of the evidence Disease Control Priorities (DCP3). Building on its predecessors, DCP1 (1993) and DCP2 (2006) published for the World Bank by Oxford University Press, the third edition provides the most up-to-date evidence on intervention efficacy and program effectiveness for the leading causes of global disease burden. It goes beyond previous efforts by providing systematic economic evaluation of policy choices affecting the access, uptake, and quality of interventions and delivery platforms for low-and middle-income countries. DCP3 introduces new extended cost-effectiveness analysis methods for assessing the equity and financial protection considerations of health and macroeconomic policies for extending coverage of proven effective interventions to prevent and treat infectious and chronic diseases, including conditions related to environmental health, trauma and mental disorders. The Series Editors of DCP3 are Dean Jamison, Hellen Gelband, Sue Horton, Prabhat Jha, Ramanan Laxminarayan, Rachel Nugent, and Charlie Mock. The volumes are published electronically and in print and individual chapters are available for download here.
Strengthening the capacity of evidence based decision-making
UW-DGH is working with global, regional and national partners in Sub-Saharan Africa, Latin America, China and the Middle East to conduct economic evaluation of the prevention and treatment of the most pressing conditions and diseases contributing to the global burden of disease through training workshops and collaborative research. Together, these components will provide the most comprehensive and up-to-date economic information to guide regional and national level policymaking, along with improved economic tools and more dispersed capacity for evidence-based priority-setting for health.